These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1330845)

  • 41. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
    Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
    Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
    Heintges T; Niederau C
    Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
    Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
    Gregorio GV; Choudhuri K; Ma Y; Pensati P; Iorio R; Grant P; Garson J; Bogdanos DP; Vegnente A; Mieli-Vergani G; Vergani D
    Clin Exp Immunol; 2003 Sep; 133(3):404-13. PubMed ID: 12930368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serological indices of autoimmunity in an Italian case-load of chronic active HBsAg positive and negative hepatitis].
    Del Vecchio-Blanco C; Caporaso N; Balzano A; Ambrogio G; Rocco P; DiSapio M
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):30-3. PubMed ID: 6383427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Etiology of chronic hepatitis in France: predominant role of hepatitis C virus.
    Hammel P; Marcellin P; Martinot-Peignoux M; Pham BN; Degott C; Level R; Lefort V; Benhallem A; Erlinger S; Benhamou JP
    J Hepatol; 1994 Oct; 21(4):618-23. PubMed ID: 7529273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis C infection in BMT patients.
    Kolho E; Ruutu P; Ruutu T
    Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti GOR and hepatitis c virus in autoimmune liver disease.
    Garg P
    Trop Gastroenterol; 1992; 13(3):120-1. PubMed ID: 1336907
    [No Abstract]   [Full Text] [Related]  

  • 49. Update of the simplified criteria for autoimmune hepatitis: Evaluation of the methodology for immunoserological testing.
    Galaski J; Weiler-Normann C; Schakat M; Zachou K; Muratori P; Lampalzer S; Haag F; Schramm C; Lenzi M; Dalekos GN; Lohse AW
    J Hepatol; 2021 Feb; 74(2):312-320. PubMed ID: 32730794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.
    Barnes RE; Meyer RA; Gordon SC
    Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type 2 autoimmune hepatitis and hepatitis C virus infection.
    Lenzi M; Ballardini G; Fusconi M; Cassani F; Selleri L; Volta U; Zauli D; Bianchi FB
    Lancet; 1990 Feb; 335(8684):258-9. PubMed ID: 1967721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers].
    Aymard JP; Botte C; Contal P; Janot C; Streiff F
    Pathol Biol (Paris); 1993 Feb; 41(2):149-53. PubMed ID: 8327265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison between first- and second-generation test for anti-hepatitis C virus antibodies in hemodialysis patients.
    Da Porto A; Poli P; Calzavara P; Castelletto MR; Adami A; Cascone C; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):367-8. PubMed ID: 1323794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Second-generation RIBA to confirm diagnosis of HCV infection.
    Lancet; 1991 Apr; 337(8746):912-3. PubMed ID: 1672986
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study.
    Gessoni G; Manoni F
    Eur J Med; 1993 Feb; 2(2):79-82. PubMed ID: 7504974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection.
    Durazzo M; Michel G; Philipp T; Braun HB; Luttig B; Rizzetto M; Manns M
    Int J Clin Lab Res; 1994; 24(4):227-9. PubMed ID: 7894050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.
    Amin K; Rasool AH; Hattem A; Al-Karboly TA; Taher TE; Bystrom J
    World J Gastroenterol; 2017 Feb; 23(8):1345-1352. PubMed ID: 28293081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoimmune factors in African cirrhosis. Correlation with hepatitis B surface antigen and antibody.
    Sadikali F; Doniach D
    Am J Gastroenterol; 1975 Dec; 64(6):484-9. PubMed ID: 1083141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.